Trial Profile
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Pharmacodynamics
- 28 Aug 2020 Status changed from recruiting to completed.
- 20 Feb 2009 New trial record